0001546417-16-000213.txt : 20161103 0001546417-16-000213.hdr.sgml : 20161103 20161103215511 ACCESSION NUMBER: 0001546417-16-000213 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161101 FILED AS OF DATE: 20161103 DATE AS OF CHANGE: 20161103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bloomin' Brands, Inc. CENTRAL INDEX KEY: 0001546417 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-EATING PLACES [5812] IRS NUMBER: 208023465 STATE OF INCORPORATION: FL FISCAL YEAR END: 1228 BUSINESS ADDRESS: STREET 1: 2202 NORTH WEST SHORE BOULEVARD STREET 2: SUITE 500 CITY: TAMPA STATE: FL ZIP: 33607 BUSINESS PHONE: 813-282-1225 MAIL ADDRESS: STREET 1: 2202 NORTH WEST SHORE BOULEVARD STREET 2: SUITE 500 CITY: TAMPA STATE: FL ZIP: 33607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SMITH ELIZABETH A CENTRAL INDEX KEY: 0001209033 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35625 FILM NUMBER: 161973505 MAIL ADDRESS: STREET 1: 1345 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10105 4 1 wf-form4_147822449891963.xml FORM 4 X0306 4 2016-11-01 0 0001546417 Bloomin' Brands, Inc. BLMN 0001209033 SMITH ELIZABETH A 2202 NORTH WEST SHORE BLVD SUITE 500 TAMPA FL 33607 1 1 0 0 Chairman and CEO Common Stock 2016-11-01 4 M 0 125000 6.50 A 167313 D Common Stock 2016-11-01 4 S 0 125000 17.195 D 42313 D Common Stock 2016-11-02 4 M 0 125000 6.50 A 167313 D Common Stock 2016-11-02 4 S 0 125000 17.112 D 42313 D Common Stock 2016-11-03 4 M 0 37576 6.50 A 79889 D Common Stock 2016-11-03 4 S 0 37576 17.079 D 42313 D Stock Option (right to buy) 6.5 2016-11-01 4 M 0 125000 6.50 D 2019-11-16 Common Stock 125000.0 3475000 D Stock Option (right to buy) 6.5 2016-11-02 4 M 0 125000 6.50 D 2019-11-16 Common Stock 125000.0 3350000 D Stock Option (right to buy) 6.5 2016-11-03 4 M 0 37576 6.50 D 2019-11-16 Common Stock 37576.0 3312424 D Restricted Stock Units 0.0 Common Stock 112010.0 112010 D Stock Option (right to buy) 17.15 2026-02-25 Common Stock 261122.0 261122 D Stock Option (right to buy) 25.36 2025-02-26 Common Stock 220589.0 220589 D Stock Option (right to buy) 25.32 2024-02-27 Common Stock 177940.0 177940 D Stock Option (right to buy) 10.03 2021-07-01 Common Stock 550000.0 550000 D Price reflected is the weighted-average sales price for the shares sold. The shares were sold in multiple transactions, and the range of sale prices for the transactions reported was $17.09 to $17.52. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or any staff member of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each separate price Price reflected is the weighted-average sales price for the shares sold. The shares were sold in multiple transactions, and the range of sale prices for the transactions reported was $17.00 to $17.29. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or any staff member of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each separate price. Price reflected is the weighted-average sales price for the shares sold. The shares were sold in multiple transactions, and the range of sale prices for the transactions reported was $17.00 to $17.25. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or any staff member of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each separate price. These stock options are fully vested. These restricted stock units, in the original grant amount of 112,010, will begin vesting in four equal annual installments on February 25, 2017. This field is not applicable. These stock options, in the original grant amount of 261,122, will begin vesting in four equal annual installments beginning on February 25, 2017. These stock options, in the original grant amount of 220,589, began vesting in four equal annual installments on February 26, 2016. These stock options, in the original grant amount of 177,940, began vesting in four equal annual installments on February 27, 2015. /s/ Kelly Lefferts, as Attorney-in-Fact 2016-11-03